• 1
    Begg CB. Selection of patients for clinical trials. Semin Oncol. 1988; 15: 434440.
  • 2
    Wittes RE, Friedman MA. Accrual to clinical trials. J Natl Cancer Inst. 1998; 80: 884885.
  • 3
    American Medical Association Council on Scientific Affairs. Viability of cancer clinical research: patient accrual, coverage, and reimbursement. J Natl Cancer Inst. 1991; 83: 254259.
  • 4
    Fischer B. Clinical trial participation. J Clin Oncol. 1991; 9: 19271930.
  • 5
    Winn RJ. Obstacles to the accrual of patients to clinical trials in the community setting. Semin Oncol. 1994; 21: (4 Suppl 7); 112117.
  • 6
    Bacon M. The evolving role of nurses in clinical trials. Can Oncol Nurs J. 1997; 7: 7980.
  • 7
    Bujorian GA. Clinical trials: patient issues in the decision-making process. Oncol Nurs Forum. 1988; 15: 779783.
  • 8
    McEvoy MD, Cannon L, DacDermott ML. The professional role for nurses in clinical trials. Semin Oncol Nurs. 1991; 7: 268274.
  • 9
    Engelking C. Facilitating clinical trials—the expanding role of the nurse. Cancer. 1991; 67: 17931797.
  • 10
    Aaronson NK, Visser-Pol E, Leenhouts GH, et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol. 1996; 14: 984996.
  • 11
    Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist. 1990; 30: 100106.
  • 12
    Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of literature. Ann Oncol. 2000; 11: 939945.
  • 13
    Taylor KM, Kelner M. Interpreting physician participation in randomised clinical trials: the Physician Orientation Profile. J Health Soc Behav. 1987; 28: 389400.
  • 14
    Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomised clinical trial of surgery for breast cancer. N Engl J Med. 1984; 310: 13631367.
  • 15
    Langley GR, Sutherland HJ, Wong S, et al. Why are (or are not) patients given the option to enter clinical trials? Control Clin Trials. 1987; 8: 4959.
  • 16
    Benson AB, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients on to clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991; 9: 20672075.
  • 17
    McCusker J, Wax A, Bennett JM. Cancer patient accessions into clinical trials. Am J Clin Oncol. 1982; 5: 227236.
  • 18
    Winn RJ, Miransky J, Kerner JF, et al. An evaluation of physician determinants in the referral of patients for cancer clinical trials in the community setting. In: EngstromPF, AndersonPN, MortensonLE, editors. Advances in cancer control: epidemiology and research. New York: Alan R. Liss, Inc., 1984: 6373.
  • 19
    Llewellyn-Thomas HA, McGreal MJ, Thiel ZC, et al. Patients willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991; 32: 3542.
  • 20
    Seldon JM, Fetting JH, Siminoff LA. Offering the option of randomized clinical trials to cancer patients who overestimate their prognosis with standard therapies. Cancer Invest. 1993; 11: 5762.
  • 21
    Kass NE, Sugarman J, Faden R, Schoch-Spana M. Trust: the fragile foundation of contemporary biomedical research. Hastings Center Rep. 1996; 26: 2529.
  • 22
    Mackillop WI, Palmer MJ, O'Sullivan B, et al. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer. 1989; 50: 388395.
  • 23
    Krueger RA. Focus groups: a practical guide for applied research. Thousand Oaks, CA: Sage, 1994.
  • 24
    Carey MA, Smith MW. Capturing the group effect in focus groups: a special concern in analysis. Qualitative Health Res. 1994; 4: 123127.
  • 25
    Morgan DL. Focus groups as qualitative research. Newbury Park, CA: Sage, 1988.
  • 26
    Bernard H. Research methods in anthropology: qualitative and quantitative approaches. Thousand Oaks, CA: Sage, 1994.
  • 27
    Ellis PM, Dowsett SM, Butow PH, Tattersal MHN. Attitudes to randomized clinical trials amongst outpatients attending a medical oncology clinic. Health Expectations. 1999; 2: 3334.
  • 28
    Albrecht TL, Blanchard C, Ruckdeschel JC, et al. Strategic physician communication and oncology clinical trials. J Clin Oncol. 1999; 17: 33243332.
  • 29
    Grant CH, Cissna KN, Rosenfeld LB. Patients' perceptions of physicians communication and outcomes of the accrual to trial process. Health Comm. 2000; 12: 2339.
  • 30
    Brown JB, Boles M, Mullooly JP, Levinson W. Effect of clinician communication skills training on patient satisfaction. A randomized, controlled trial. Ann Intern Med. 1999; 131: 859860.
  • 31
    Fallowfield L, Ratcliffe D, Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer 1997; 33: 22212229.
  • 32
    Siminoff LA, Fetting JH, Abeloff MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol. 1980; 7: 11921200.